GlassScriptPhysician profile
Danielle Nicole Lewis
NPI 1619587904
$1,115.39
in general payments reported to CMS, 2019-2025
17 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.47 · 2022: $126 · 2023: $412 · 2024: $322 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $436.96 | 2021-2025 | |
| Incyte Corporation | $188.75 | 2022-2024 | Opzelura |
| Janssen Biotech, INC. | $124.52 | 2023-2025 | Tremfya, Simponi Aria, Remicade |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $60.85 | 2023-2024 | Arazlo, Cabtreo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.31 | 2022-2024 | Cyltezo |
| Genentech USA, INC. | $37.66 | 2023-2024 | Erivedge |
| Amgen INC. | $32.75 | 2024 | Otezla |
| Sun Pharmaceutical Industries INC. | $31.68 | 2023 | Blu-U |
| Regeneron Healthcare Solutions, INC. | $20.00 | 2024 | Libtayo |
| Lilly USA, LLC | $19.99 | 2024 | Olumiant |
| Biofrontera INC. | $19.44 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Mayne Pharma Commercial LLC | $18.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.60 | 2025 | |
| Exeltis, USA INC. | $16.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.93 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $15.15 | 2024 | |
| Helsinn Therapeutics (U.S.), INC. | $12.98 | 2023 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.